Longview Home Page Marshal Home Page Linden Home Page
Health News Health Library Health Topics Healthy Living
Today's Headlines    Health Alerts    Health News Feature   
Future of Medicine    Health Observances    Product Recalls
Illnesses & Conditions    Drug Guide    FDA Drug Approvals    Medical Tests   
Self-Help Resources    Complementary Medicine    Medline Search
Allergies    Asthma    Back Pain    Cancer    Caregiver    Depression    Diabetes    Digestive Disorders
Heart Disease    Kidney Disease    Men's Health    Parenting    Pregnancy    Senior's Health
Stress    Stroke    Women's Health
Fitness    Nutrition    Mind & Body    Family & Home
 






SEARCH



Today's Headlines

Health News
Daily articles from HealthDay News: breaking news on health issues, drug approvals and recent discoveries.

Donor's Age Not Linked to Poor Outcomes in Liver Transplants


Even recipients with hepatitis C had good five-year survival rates, study finds

TUESDAY, July 22 (HealthDay News) -- Patients with hepatitis C who receive a liver from a donor over age 60 aren't at an increased risk for transplant failure, death or recurrent disease within five years after transplantation, say researchers at the Washington University School of Medicine, in St. Louis.

They analyzed data from 489 adults who had liver transplants at the school between 1997 and 2006. Of those patients, 187 (38.2 percent) had hepatitis C and 302 (61.8 percent) had other indications for liver transplant.

Of the patients with hepatitis C, 88.1 percent were still alive after one year, 78.3 percent survived three years, and 69.2 percent survived five years. Donor livers were still functioning in 85.6 percent of hepatitis C virus-positive recipients after one year, 75.6 percent after three years, and 65.6 percent after five years.

When they compared patients with hepatitis C and those without hepatitis C, the researchers found no differences in rates of patient survival and transplanted liver survival at one, three and five years.

"However, similar to other long-term transplant centers, we observed a negative effect from recurrent hepatitis C virus with a trend toward worsened long-term survival between years five and 10," the researchers wrote.

Among the patients in the study, 24 (12.8 percent) of those with hepatitis C and 48 (15.9 percent) of those without the virus received livers from donors age 60 and older. These recipients and those who received livers from younger donors had similar one-, three-, and five-year survival rates.

The findings were published in the July issue of the Archives of Surgery.

"In conclusion, overall patient and graft (organ) survival in hepatitis C virus-positive recipients is comparable with that in hepatitis C virus-negative patients, and there seems to be little, if any, adverse effect on short- and medium-term follow-up with the use of carefully selected older donor grafts in recipients with hepatitis C virus," the researchers concluded. "Data from this series suggest that the continued use of selected older donors is a safe method of expanding the liver donor pool, even for hepatitis C-positive recipients."

More information

The U.S. Centers for Disease Control and Prevention has more about hepatitis C.

SOURCE: JAMA/Archives journals, news release, July 21, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Health News Provided By:
HealthDay


 

 
Good Shepherd Health

Data and information on this site
has been compiled for public use.
GSMC will not be held liable for
errors or inaccuracies.
Privacy & Conditions of Use Policy.
Questions/Comments? Contact
webmaster.
© 1999-2002 Good Shepherd Health System
Recommended Browsers:
Microsoft Internet Explorer
Version 4.0 or above,
Netscape Navigator 4.0 or above,
Or Any HTML 4.0 browser.

.